JP2023527209A5 - - Google Patents
Info
- Publication number
- JP2023527209A5 JP2023527209A5 JP2022573285A JP2022573285A JP2023527209A5 JP 2023527209 A5 JP2023527209 A5 JP 2023527209A5 JP 2022573285 A JP2022573285 A JP 2022573285A JP 2022573285 A JP2022573285 A JP 2022573285A JP 2023527209 A5 JP2023527209 A5 JP 2023527209A5
- Authority
- JP
- Japan
- Prior art keywords
- lag
- protein
- pharmaceutical composition
- amino acid
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2008037.0A GB202008037D0 (en) | 2020-05-28 | 2020-05-28 | Treatment of cancer |
| GB2008037.0 | 2020-05-28 | ||
| RU2020131384 | 2020-09-23 | ||
| RU2020131384A RU2020131384A (ru) | 2020-05-28 | 2020-09-23 | Лечение рака |
| GB2018062.6 | 2020-11-17 | ||
| GBGB2018062.6A GB202018062D0 (en) | 2020-11-17 | 2020-11-17 | Treatment of cancer |
| PCT/EP2021/057588 WO2021239292A1 (en) | 2020-05-28 | 2021-03-24 | Treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023527209A JP2023527209A (ja) | 2023-06-27 |
| JP2023527209A5 true JP2023527209A5 (https=) | 2024-04-05 |
Family
ID=75362569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573285A Pending JP2023527209A (ja) | 2020-05-28 | 2021-03-24 | がんの治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230210946A1 (https=) |
| EP (1) | EP4157313A1 (https=) |
| JP (1) | JP2023527209A (https=) |
| KR (1) | KR20230028321A (https=) |
| CN (1) | CN116133674A (https=) |
| AU (1) | AU2021280214A1 (https=) |
| BR (1) | BR112022024179A2 (https=) |
| CA (1) | CA3184309A1 (https=) |
| IL (1) | IL298507A (https=) |
| MX (1) | MX2022014909A (https=) |
| WO (1) | WO2021239292A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4475955A1 (en) * | 2022-02-11 | 2024-12-18 | Immutep S.A.S. | Treatment of cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2044949A1 (en) | 2007-10-05 | 2009-04-08 | Immutep | Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response |
| GB201322626D0 (en) * | 2013-12-19 | 2014-02-05 | Immutep S A | Combined preparations for the treatment of cancer |
| GB201500374D0 (en) * | 2015-01-09 | 2015-02-25 | Immutep S A | Combined preparations for the treatment of cancer |
| JP2021534177A (ja) * | 2018-08-16 | 2021-12-09 | ジー１ セラピューティクス， インコーポレイテッド | 医学的障害を治療するためのベンゾチオフェンエストロゲン受容体モジュレーター |
| WO2020047329A1 (en) * | 2018-08-29 | 2020-03-05 | Shattuck Labs, Inc. | Chimeric proteins comprising extracellular domains and uses thereof |
-
2021
- 2021-03-24 IL IL298507A patent/IL298507A/en unknown
- 2021-03-24 BR BR112022024179A patent/BR112022024179A2/pt unknown
- 2021-03-24 MX MX2022014909A patent/MX2022014909A/es unknown
- 2021-03-24 CA CA3184309A patent/CA3184309A1/en active Pending
- 2021-03-24 WO PCT/EP2021/057588 patent/WO2021239292A1/en not_active Ceased
- 2021-03-24 JP JP2022573285A patent/JP2023527209A/ja active Pending
- 2021-03-24 US US17/928,048 patent/US20230210946A1/en active Pending
- 2021-03-24 KR KR1020227046217A patent/KR20230028321A/ko active Pending
- 2021-03-24 AU AU2021280214A patent/AU2021280214A1/en active Pending
- 2021-03-24 CN CN202180059063.2A patent/CN116133674A/zh active Pending
- 2021-03-24 EP EP21716087.8A patent/EP4157313A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020286248B2 (en) | Collagen Peptide-Based Medicament Compositions And Devices And Methods Of Production And Use Thereof | |
| JP2019203035A5 (https=) | ||
| JP2022048388A (ja) | 代謝機能不全によって引き起こされる腫瘍の治療 | |
| JP2021505661A5 (https=) | ||
| JP2010503386A5 (https=) | ||
| RU2021130306A (ru) | Композиции il-12, нацеленные на edb | |
| JP2021514661A5 (https=) | ||
| KR20150065881A (ko) | 암 표적화 치료 및 암 재발 예방을 위한 헤모글로빈 기반 산소운반체 함유 약학적 조성물 | |
| JP2020517658A5 (https=) | ||
| JP2020535161A5 (https=) | ||
| JP2024540275A5 (https=) | ||
| JP2021514354A5 (https=) | ||
| JP2022523530A5 (https=) | ||
| TW202440171A (zh) | 治療前列腺癌之方法 | |
| JP2024542682A5 (https=) | ||
| CN103370066A (zh) | 用于治疗癌症的包含威罗菲尼和干扰素的组合疗法 | |
| JP2011506436A (ja) | 細胞傷害性ｔリンパ球抗原４（ｃｔｌａ４）に対する抗体と組み合わせられたアルファチモシンペプチドによる黒色腫の処置の方法 | |
| JP2023527209A5 (https=) | ||
| Lewis et al. | NK1 receptor antagonists and dexamethasone as anticancer agents in vitro and in a model of brain tumours secondary to breast cancer | |
| Chen et al. | Research progress in targeted therapy of hepatocellular carcinoma | |
| JP6782932B2 (ja) | Ｎｐｒ−ａアゴニストの新規用途 | |
| JP2014523437A (ja) | 癌の予防および治療における効力のある薬剤としての新規亜鉛フィンガー様ペプチド組成物 | |
| JP2014515393A (ja) | 腫瘍性疾患治療の組合せ医薬組成物 | |
| JP7824885B2 (ja) | 表皮水疱症の治療で使用するためのホーミングペプチド誘導デコリン複合体 | |
| JP2025505738A5 (https=) |